10-K: IB Acquisition Corp. Extends Deadline Amidst Significant Share Redemptions
Annual Report
IB Acquisition Corp. secured a business combination deadline extension to March 2026, but faced substantial share redemptions, significantly reducing its trust account balance.
Summary
- IB Acquisition Corp. is a blank check company (SPAC) formed for a business combination, targeting high-growth companies in consumer goods, sports and entertainment, and healthcare technology, with an enterprise value of at least $500 million.
- Stockholders approved an extension of the business combination deadline from September 28, 2025, to March 28, 2026.
- In connection with the extension vote, 10,009,120 shares of common stock were redeemed at an approximate price of $10.60 per share, totaling approximately $106.1 million.
- The trust account balance was significantly reduced from $118.6 million as of September 30, 2024, to approximately $15.8 million as of September 30, 2025, after these redemptions.
- The company reported a net income of $3,416,169 for the fiscal year ended September 30, 2025, primarily from interest earned on the trust account, compared to $1,867,387 in 2024.
- A 1% excise tax of $1,061,310 was recorded as payable due to the share redemptions under the Inflation Reduction Act of 2022.
- Management has determined that the company currently lacks the liquidity needed to sustain operations for a reasonable period, raising substantial doubt about its ability to continue as a going concern.
- Disclosure controls and procedures were deemed not effective as of September 30, 2025, due to inadequate segregation of duties and insufficient written policies and procedures.
Sentiment
Score: 2
Explanation: The company faces severe challenges, including massive share redemptions, a significantly depleted trust account, a stated 'going concern' risk, and ineffective internal controls. While an extension was secured, the capital available for an acquisition is minimal, making a successful business combination highly uncertain and dilutive for remaining shareholders.
Positives
- Successfully extended the business combination deadline to March 28, 2026, providing additional time to identify and complete an acquisition.
- Reported increased net income of $3,416,169 for the fiscal year ended September 30, 2025, compared to $1,867,387 in 2024, driven by interest and dividends earned on trust account investments.
- The management team and board members possess significant experience in private investing, corporate finance, restructuring, and executive management across diverse industries and geographies, which could be beneficial for sourcing and evaluating target businesses.
Negatives
- Experienced massive share redemptions of 10,009,120 shares, totaling approximately $106.1 million, which severely depleted the trust account.
- The trust account balance decreased from $118.6 million to approximately $15.8 million, significantly limiting the capital available for an initial business combination.
- Management explicitly identified a 'going concern' risk due to insufficient liquidity to sustain operations for a reasonable period of time.
- Disclosure controls and procedures were deemed 'not effective' as of September 30, 2025, citing inadequate segregation of duties and insufficient written policies.
- Incurred a $1,061,310 excise tax payable due to share redemptions under the Inflation Reduction Act of 2022.
- The company has a working capital deficit of $588,202 as of September 30, 2025.
Risks
- Public stockholders may not be afforded an opportunity to vote on the proposed initial business combination, and founder shares will participate in any vote, potentially approving a combination not supported by public stockholders.
- The ability of public stockholders to redeem shares for cash may make the financial condition unattractive to potential business combination targets, hindering the ability to enter into a business combination.
- Large redemptions could prevent the completion of the most desirable business combination or optimize the capital structure.
- The deadline for completing a business combination (March 28, 2026) may give target businesses leverage over the company in negotiations and decrease the ability to conduct due diligence.
- Failure to complete an initial business combination within the prescribed time frame would lead to liquidation, with public stockholders receiving approximately $10.05 per share (or less) and rights expiring worthless.
- The company is not required to obtain an independent opinion on the fairness of the business combination price, unless with an affiliated entity or if the board cannot independently determine fair market value.
- Potential conflicts of interest exist due to management's involvement with other entities and the sponsor's financial incentive to complete a deal.
- Lack of business diversification post-combination, as the company will likely depend on a single business.
- Increased competition from other SPACs and entities for attractive target businesses could raise acquisition costs or prevent finding a suitable target.
- Changes in the market for directors and officers liability insurance could increase costs and difficulty in completing a business combination.
- Issuance of shares to investors in connection with a business combination at a price less than the prevailing market price could dilute existing shareholders.
- Executive officers and directors allocate time to other businesses, potentially causing conflicts of interest.
- The nominal purchase price paid by the sponsor for founder shares may result in significant dilution to public shares upon business combination.
- NASDAQ may delist securities, limiting liquidity and subjecting the company to additional trading restrictions.
- Third-party claims against the trust account could reduce the per-share redemption amount.
- Negative interest rates on trust account investments could reduce redemption amounts.
- Directors may choose not to enforce sponsor indemnification obligations, further reducing trust funds.
- Bankruptcy proceedings could subject trust account proceeds to creditor claims, reducing stockholder distributions.
- Stockholders may be liable for third-party claims to the extent of distributions received upon redemption.
- The company may not hold an annual meeting until after a business combination, limiting stockholder input.
- The grant of registration rights to initial stockholders and private placement unit holders may make a business combination more difficult and affect market price.
- Issuance of additional shares (common or preferred) for a business combination or incentive plan could dilute existing stockholders.
- Amendments to charter or governing instruments without stockholder approval are possible.
- The Inflation Reduction Act of 2022's excise tax on stock repurchases may apply to redemptions, reducing cash available.
- The company has no operating history or revenues, making evaluation of its ability to achieve its objective difficult.
- Uncertainty regarding the applicability of the Investment Company Act, which could restrict activities or force liquidation.
- Market conditions, economic uncertainty, or downturns (e.g., geopolitical conflicts, inflation, interest rates) could adversely affect the business and ability to consummate a combination.
- Changes in laws or regulations (e.g., 2024 SPAC Rules) or failure to comply could adversely affect the business.
- Compliance obligations under the Sarbanes-Oxley Act may increase time and costs for an acquisition.
- Cyber incidents or attacks could result in information theft, data corruption, operational disruption, and financial loss.
Future Outlook
The company intends to pursue an initial business combination with high-growth companies in fintech, healthcare and life sciences, sports and entertainment, and consumer goods, targeting an enterprise value of at least $500 million. It aims to provide liquidity for owners, growth capital, and public market access for target companies. However, the ability to complete a business combination is subject to significant liquidity constraints and market conditions, with a deadline of March 28, 2026.
Management Comments
- Our management team and board members believe there are compelling investment opportunities in a number of areas including consumer goods, sports and entertainment, and healthcare technology.
- We believe our management, investing, financing and restructuring experience combined with the extensive professional relationships of our team provides us with important competitive advantages for sourcing, pursuing and evaluating an initial business combination within our target universe.
- We believe our structure will make us an attractive business combination partner to target businesses.
- Management has determined that the Company currently lacks the liquidity it needs to sustain operations for a reasonable period of time... These conditions raise substantial doubt about the Company’s ability to continue as a going concern.
Industry Context
The SPAC market has seen increased competition, making attractive targets scarcer and potentially increasing acquisition costs. The company's strategy to target high-growth sectors like fintech, healthcare, sports, and consumer goods aligns with current investor interest in these areas. However, the significant redemptions and reduced trust size place it at a disadvantage compared to other SPACs with larger capital pools, especially in a volatile economic environment marked by geopolitical instability and rising interest rates.
Comparison to Industry Standards
- The company's target enterprise value of at least $500 million is a common benchmark for SPACs seeking substantial acquisitions, though its current available capital of $15.8 million in the trust account is significantly lower than typical SPACs at this stage, requiring substantial additional financing.
- The high redemption rate of over 87% (10,009,120 out of 11,500,000 public shares) is considerably higher than the average redemption rates seen in the SPAC market in recent years, which typically range from 50-70%, indicating a strong lack of confidence from public shareholders in the company's ability to find a suitable target or in the extension itself.
- The declaration of 'not effective' internal controls due to limited personnel and insufficient policies is a significant governance concern, potentially below the standards expected for a publicly traded entity, even an emerging growth company.
- The imposition of a 1% excise tax on redemptions, as per the Inflation Reduction Act, is a new industry-wide factor affecting SPACs, adding to the cost of redemptions and reducing available capital.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer | Unknown (resigned) | Christy Albeck | 2024-01-22 | Previous CFO resigned; new CFO appointed. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Committee Composition | Audit, Compensation, and Nominating and Corporate Governance Committees are composed solely of independent directors. | N/A (established with IPO) | Aims to enhance oversight and independence, aligning with Nasdaq listing standards. |
| Code of Ethics | Adopted a Code of Ethics applicable to directors, officers, and employees. | N/A (filed with IPO registration) | Establishes ethical guidelines and promotes compliance. |
| Insider Trading Policy | Adopted an insider trading policy requiring insiders to refrain from purchasing shares during blackout periods and clear trades with legal counsel. | N/A (filed with previous 10-K) | Aims to prevent insider trading and maintain market integrity. |
| Clawback Policy | Adopted a Clawback Policy. | N/A (filed with previous 10-K) | Allows recovery of incentive-based compensation in certain circumstances, enhancing accountability. |
| Internal Control Effectiveness | Disclosure controls and procedures were not effective as of September 30, 2025, due to inadequate segregation of duties and insufficient written policies. | 2025-09-30 | Indicates a material weakness in financial reporting controls, requiring remediation to ensure accuracy and reliability of financial information. |
Legal Proceedings
- No material litigation, arbitration, or governmental proceeding currently pending against the company or its management.
Related Party Transactions
- Sponsor (I-B Good Works 4, LLC) subscribed for 3,243,590 founder shares for $3,000.
- Sponsor purchased 610,500 private placement units for $6,105,000.
- Sponsor incurred $2,788 in travel expenses reimbursable by Su De Tang Global Corporation.
- Subscription agreements for membership interests in the Sponsor were entered into with management, directors, and director nominees, representing indirect ownership of founder shares.
- Administrative Services Agreement with Christy Albeck (CFO) for $5,000 per month for office space, utilities, secretarial support, and administrative/consulting services.
- Initial stockholders, executive officers, and directors are reimbursed for any out-of-pocket expenses incurred in connection with activities on the company's behalf.
- Sponsor or an affiliate of the sponsor or certain officers and directors may loan funds for working capital, with up to $1,500,000 of such loans convertible into private placement-equivalent units at $10.00 per unit.
- I-Bankers (an affiliate of the Sponsor) was engaged for business combination marketing services, with a cash fee of 3.5% of the gross proceeds of the Initial Public Offering ($4,025,000) payable upon consummation of a business combination, and a potential 1.0% finder's fee.
Stakeholder Impact
- Shareholders: Remaining public shareholders face significant dilution risk from founder shares and potential future equity raises. The substantial reduction in trust funds and the 'going concern' warning create high uncertainty regarding the value of their investment.
- Management: Highly incentivized to complete a business combination due to their founder shares and potential post-deal compensation, but face considerable challenges in securing a suitable target with limited available capital.
- Creditors: Potential risk if the company liquidates without sufficient funds to cover all claims, despite the sponsor's agreement to indemnify the trust account under certain conditions.
- Potential Target Businesses: The company's significantly reduced capital and stated 'going concern' status may make it a less attractive merger partner, potentially limiting the pool of suitable acquisition targets.
Next Steps
- Identify and evaluate target businesses for an initial business combination.
- Perform business due diligence on prospective target businesses.
- Structure, negotiate, and complete a business combination by March 28, 2026.
- Recruit additional managers post-business combination if needed.
- Evaluate internal control procedures for the fiscal year ending September 30, 2026, as required by Sarbanes-Oxley Act.
Key Dates
| Date | Description |
|---|---|
| 2020-07-07 | Company originally formed under Delaware laws. |
| 2020-09-02 | Sponsor subscribed to purchase 4,312,500 founder shares for $3,000. |
| 2023-09-21 | Company converted to a Nevada corporation. |
| 2023-10-01 | Administrative Services Agreement with previous CFO commenced ($5,000 per month). |
| 2023-10-26 | Sponsor surrendered 1,068,910 common shares, reducing founder shares to 3,243,590. |
| 2023-11-15 | Valuation date for founder shares (first batch). |
| 2023-12-29 | John Joyce appointed Vice Chairman. |
| 2024-01-15 | Valuation date for founder shares (second batch). |
| 2024-01-22 | Previous CFO resigned, Administrative Services Agreement terminated. New CFO Christy Albeck appointed. |
| 2024-01-24 | New Administrative Services Agreement with Christy Albeck commenced ($5,000 per month). SEC issued final 2024 SPAC Rules, effective July 1, 2024. |
| 2024-02-28 | Sponsor distributed 1,016,514 founder shares to James Michael McCrory. |
| 2024-03-25 | Registration statement for IPO declared effective. Letter Agreement, Investment Management Trust Agreement, Registration Rights Agreement, and Business Combination Marketing Agreement dated. |
| 2024-03-28 | Initial Public Offering (IPO) consummated (11,500,000 units at $10.00 per unit). Private sale of 610,500 Private Placement Units to Sponsor. Units commenced public trading. |
| 2024-05-01 | Common stock and rights began separate trading; units ceased trading. |
| 2024-09-11 | Subscription agreement amended, granting additional 50,000 founder shares to directors/nominees. |
| 2024-09-16 | Company issued unsecured promissory note of $150,000 to Su De Tang Global Corporation (Working Capital Loan). |
| 2024-10-31 | Filing and payment deadline for 1% excise tax incurred from Jan 1, 2023 to Dec 31, 2023 (per IRS Announcement 2023-18). |
| 2025-09-22 | Special Meeting held; stockholders approved extension of business combination deadline to March 28, 2026. Stockholders holding 10,009,120 shares exercised redemption rights. |
| 2025-09-28 | Redemptions of 10,009,120 shares effected, removing approximately $106.1 million from Trust Account. |
| 2025-09-30 | Fiscal year ended. |
| 2025-10-01 | Christy Albeck began serving as Founder and Managing Member of Albeck Advisors. |
| 2025-12-29 | Date of this 10-K filing. |
| 2026-03-28 | Extended deadline to complete initial business combination. |
| 2026-09-30 | Fiscal year end for which internal control procedures evaluation is required by Sarbanes-Oxley Act. |
Recommendation
sellThe company faces severe financial distress, evidenced by the 'going concern' warning and the massive redemption of over 87% of its public shares, leaving only $15.8 million in its trust account. This significantly impairs its ability to complete a meaningful business combination, especially given its stated target enterprise value of at least $500 million. The ineffective internal controls further highlight operational weaknesses. While an extension was granted, the fundamental issues of insufficient capital and high shareholder redemptions make a successful outcome highly improbable, suggesting a 'sell' recommendation for investors to minimize further potential losses.
Keywords
SPAC, Blank Check Company, Business Combination, SEC Filing, 10-K, Financial Report, Share Redemptions, Trust Account, Going Concern, Corporate Governance, Risk Factors, NASDAQ, Merger and Acquisition, Financial Performance, Internal Controls, Inflation Reduction Act, Excise Tax, Public Company, Investment Opportunities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.